Trial intelligence / Profile preview

Oral Magnesium for Neuropathic Pain

NCT01121653Phase 4Completed

Sponsor
Centre Hospitalier Universitaire de Clermont-Ferrand
Start
Mar 2006
Primary completion
Jan 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of Magnogene in neuropathic pain, sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Started Mar 2006; status: completed.

02

Drugs

Magnogene
03

Conditions

neuropathic pain

Beyond the preview

Go deeper on NCT01121653.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01121653.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call